Switching biological disease-modifying antirheumatic drugs in patients with axial spondyloarthritis: results from a systematic literature review

OBJECTIVES: First, to investigate if switching biological disease-modifying antirheumatic drugs (bDMARDs) after the failure to prior bDMARD is efficacious in patients with axial spondyloarthritis (axSpA). Second, to evaluate the influence on this efficacy of (1) the reason to discontinue prior tumou...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:RMD Open
Hlavní autoři: Navarro-Compán, Victoria, Plasencia-Rodríguez, Chamaida, de Miguel, Eugenio, Diaz del Campo, Petra, Balsa, Alejandro, Gratacós, Jordi
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2017
Témata:
Spondyloarthritis
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5640114/
https://ncbi.nlm.nih.gov/pubmed/29071119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2017-000524
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky